|
MGEA5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.85390036655519E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.97100171926013E-11 |
| Normal-vs-Stage2 |
1.794790E-04 |
| Normal-vs-Stage3 |
7.86190000000575E-05 |
| Normal-vs-Stage4 |
3.449700E-04 |
| Stage1-vs-Stage2 |
8.793000E-01 |
| Stage1-vs-Stage3 |
9.328300E-02 |
| Stage1-vs-Stage4 |
5.100200E-02 |
| Stage2-vs-Stage3 |
2.115200E-01 |
| Stage2-vs-Stage4 |
1.806600E-01 |
| Stage3-vs-Stage4 |
8.006800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.74510011680718E-10 |
| Normal-vs-AfricanAmerican |
3.50740000000238E-05 |
| Normal-vs-Asian |
1.995310E-04 |
| Caucasian-vs-AfricanAmerican |
5.542800E-01 |
| Caucasian-vs-Asian |
3.728000E-01 |
| AfricanAmerican-vs-Asian |
4.949400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.60299999730063E-08 |
| Normal-vs-Female |
5.56049650768387E-11 |
| Male-vs-Female |
1.951590E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.614300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.82139986321306E-10 |
| Normal-vs-Age(61-80Yrs) |
5.05230000058532E-08 |
| Normal-vs-Age(81-100Yrs) |
4.429700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.263400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.174800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.012200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.486000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.841200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.527200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.060420E-03 |
| Normal-vs-Grade 2 |
1.42249545476147E-11 |
| Normal-vs-Grade 3 |
4.78630000078084E-08 |
| Normal-vs-Grade 4 |
1.376400E-01 |
| Grade 1-vs-Grade 2 |
3.895800E-02 |
| Grade 1-vs-Grade 3 |
2.082700E-03 |
| Grade 1-vs-Grade 4 |
3.102100E-03 |
| Grade 2-vs-Grade 3 |
5.921900E-02 |
| Grade 2-vs-Grade 4 |
7.54580000039695E-07 |
| Grade 3-vs-Grade 4 |
6.371600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.99200722162641E-16 |
| Normal-vs-ccB subtype |
1.274100E-02 |
| ccA subtype-vs-ccB subtype |
1.43109968320232E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.54930007396126E-10 |
| Normal-vs-N1 |
2.231600E-01 |
| N0-vs-N1 |
2.507900E-02 |
|
|
